Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Hay Fever Treatment Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Hay Fever Treatment Trends and Forecast

The future of the global hay fever treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global hay fever treatment market is expected to grow with a CAGR of 2.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of allergic rhinitis and growing awareness about allergic rhinitis and its management empowers patients to seek appropriate treatment options for symptom relief.
• Lucintel forecasts that antihistamine is expected to witness the highest growth over the forecast period.
• Within this market, hospital pharmacy is expected to witness the highest growth.
• North America is expected to witness the highest growth over the forecast period.

Hay Fever Treatment Trends and Forecast

United States, companies like Pfizer and Sanofi have announced initiatives to develop novel treatments targeting specific allergens, aiming to provide more personalized solutions. Meanwhile, the UK government has set targets to increase access to allergy services and improve awareness through public health campaigns.

Japan, pharmaceutical companies like Daiichi Sankyo are investing in research to develop innovative allergy treatments. Australia has seen collaborations between government agencies and pharmaceutical companies to expand treatment options and enhance patient care.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hay Fever Treatment by Segment

Hay Fever Treatment by Segment

The study includes a forecast for the global hay fever treatment by type, application, and region.

Hay Fever Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:


• Antihistamines
• Decongestants
• Corticosteroids
• Immunotherapy

Hay Fever Treatment Market by Application [Shipment Analysis by Value from 2018 to 2030]:


• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Hay Fever Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Hay Fever Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hay fever treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hay fever treatment companies profiled in this report include-
• Merck
• Boehringer Ingelheim International
• Astrazeneca
• GSK
• Johnson & Johnson Services
• Teva Pharmaceutical Industries
• Novartis
• Mylan
• Aytu Biopharma
• Glenmark Pharmaceuticals

Recent Development in the Hay Fever Treatment Market

Johnson & Johnson (J&J) announced the FDA approval of their novel hay fever treatment, Allegra-D, showcasing a significant advancement in allergy management technology. The drugÄX%$%Xs extended-release formula offers relief from hay fever symptoms for up to 24 hours, revolutionizing patient convenience and efficacy.

PfizerÄX%$%Xs recent collaboration with GlaxoSmithKline (GSK) marked a milestone in hay fever treatment. Their joint venture aims to develop a breakthrough immunotherapy targeting specific allergens, potentially offering a more personalized approach to allergy management and reducing reliance on traditional antihistamines.

Novartis introduced a game-changing nasal spray, Xolair, designed to alleviate hay fever symptoms by targeting the root cause - allergic inflammation. With its innovative mechanism of action, Xolair offers hope to millions of hay fever sufferers worldwide, promising long-lasting relief and improved quality of life.

SanofiÄX%$%Xs strategic acquisition of a leading biotech firm specializing in allergy research underscored their commitment to advancing hay fever treatment options. This move positions Sanofi at the forefront of allergy innovation, leveraging cutting-edge technology and scientific expertise to develop next-generation therapies for hay fever sufferers.

MerckÄX%$%Xs groundbreaking clinical trials for their experimental hay fever vaccine showed promising results, indicating a potential breakthrough in long-term allergy management. If successful, this vaccine could offer hay fever sufferers a more permanent solution to their symptoms, reducing the need for regular medication and improving overall quality of life.

Features of the Global Hay Fever Treatment Market

Market Size Estimates: Hay fever treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Hay fever treatment market size by type, application, and region in terms of value ($B).
Regional Analysis: Hay fever treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hay fever treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hay fever treatment market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for hay fever treatment market?
Answer: The global hay fever treatment market is expected to grow with a CAGR of 2.9% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the hay fever treatment market?
Answer: The major drivers for this market are increasing prevalence of allergic rhinitis and growing awareness about allergic rhinitis and its management empowers patients to seek appropriate treatment options for symptom relief.
Q3. What are the major segments for hay fever treatment market?
Answer: The future of the hay fever treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q4. Who are the key hay fever treatment market companies?
Answer: Some of the key hay fever treatment companies are as follows:
• Merck
• Boehringer Ingelheim International
• Astrazeneca
• GSK
• Johnson & Johnson Services
• Teva Pharmaceutical Industries
• Novartis
• Mylan
• Aytu Biopharma
• Glenmark Pharmaceuticals
Q5. Which hay fever treatment market segment will be the largest in future?
Answer: Lucintel forecasts that antihistamine is expected to witness the highest growth over the forecast period.
Q6. In hay fever treatment market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the hay fever treatment market by type (antihistamines, decongestants, corticosteroids, and immunotherapy), application (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Hay Fever Treatment Market, Hay Fever Treatment Market Size, Hay Fever Treatment Market Growth, Hay Fever Treatment Market Analysis, Hay Fever Treatment Market Report, Hay Fever Treatment Market Share, Hay Fever Treatment Market Trends, Hay Fever Treatment Market Forecast, Hay Fever Treatment Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Hay Fever Treatment Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Hay Fever Treatment Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Hay Fever Treatment Market by Type
3.3.1: Antihistamines
3.3.2: Decongestants
3.3.3: Corticosteroids
3.3.4: lmmunotherapy
3.4: Global Hay Fever Treatment Market by Application
3.4.1: Hospital Pharmacy
3.4.2: Retail Pharmacy
3.4.3: Online Pharmacy
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Hay Fever Treatment Market by Region
4.2: North American Hay Fever Treatment Market
4.2.1: North American Hay Fever Treatment Market by Type: Antihistamines, Decongestants, Corticosteroids, and lmmunotherapy
4.2.2: North American Hay Fever Treatment Market by Application: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.3: European Hay Fever Treatment Market
4.3.1: European Hay Fever Treatment Market by Type: Antihistamines, Decongestants, Corticosteroids, and lmmunotherapy
4.3.2: European Hay Fever Treatment Market by Application: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.4: APAC Hay Fever Treatment Market
4.4.1: APAC Hay Fever Treatment Market by Type: Antihistamines, Decongestants, Corticosteroids, and lmmunotherapy
4.4.2: APAC Hay Fever Treatment Market by Application: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.5: ROW Hay Fever Treatment Market
4.5.1: ROW Hay Fever Treatment Market by Type: Antihistamines, Decongestants, Corticosteroids, and lmmunotherapy
4.5.2: ROW Hay Fever Treatment Market by Application: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Hay Fever Treatment Market by Type
6.1.2: Growth Opportunities for the Global Hay Fever Treatment Market by Application
6.1.3: Growth Opportunities for the Global Hay Fever Treatment Market by Region
6.2: Emerging Trends in the Global Hay Fever Treatment Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Hay Fever Treatment Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hay Fever Treatment Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Merck
7.2: Boehringer Ingelheim International
7.3: Astrazeneca
7.4: GSK
7.5: Johnson & Johnson Services
7.6: Teva Pharmaceutical Industries
7.7: Novartis
7.8: Mylan
7.9: Aytu Biopharma
7.10: Glenmark Pharmaceuticals
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Hay Fever Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Hay Fever Treatment Market Report.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )